On lighter skin, plaque psoriasis can appear red ... People with darker skin are more likely to find psoriasis lesions on the scalp, elbows, knees, torso, buttocks, and even nails.

Plaque psoriasis is the most common form ... smooth and shiny. On skin of color, the lesions will appear purple, brown or ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

and showed that it was significantly more effective than placebo at clearing up skin lesions in patients with moderate to severe plaque psoriasis. The phase 2 study included a range of doses ...

Patients with plaque psoriasis treated with Johnson ... achieving a 76% PASI 75 response – 78.6% clearance of psoriasis skin lesions – at 52 weeks. That was pretty much in line with the ...

In the Phase III ICONIC-LEAD trial, 75% of adolescents with moderate-to-severe plaque psoriasis treated with icotrokinra achieved completely clear skin by week 24. Results from the Phase III ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

It is approved for use in rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and adults with chronic moderate-to-severe plaque psoriasis. In clinical ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque ... psoriasis the unique combination of a favorable safety profile and complete skin ...